𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of angiotensin II non-peptide AT1 antagonist losartan on phosphatidylethanolamine membranes

✍ Scribed by Efthimia Theodoropoulou; Derek Marsh

Book ID
117047725
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
485 KB
Volume
1509
Category
Article
ISSN
0005-2736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of cimetidine on pharmacokinetic
Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist
✍ M. R. Goldberg; M. W. Lo; T. E. Bradstreet; M. A. Ritter; P. HΓΆgland πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 512 KB

This was a 2-period randomized, crossover study in 8 healthy males to determine the effects of cimetidine (400 mg q.i.d. for 6 days) on the pharmacokinetics and pharmacodynamic effects of the angiotensin II receptor antagonist, losartan (100 mg). Cimetidine increased the AUC for losartan 18% without

Superimposition of potent non-peptide AT
Superimposition of potent non-peptide AT1receptor antagonists with angiotensin II
✍ Efthimia Theodoropoulou; Thomas Mavromoustakos; Dimitris Panagiotopoulos; John M πŸ“‚ Article πŸ“… 1996 πŸ› Springer Netherlands 🌐 English βš– 542 KB

The model of angiotensin II (ANG II) developed in our laboratory using a combination of NMR, fluorescence data and molecular graphics [Matsoukas, J.M. et al., J. Biol. Chem., 269 (1994) 5303] served as a template for a systematic superimposition of potent AT~ receptor antagonists with ANG II. The ke

Effect of losartan, an Angiotensin II re
Effect of losartan, an Angiotensin II receptor antagonist, on portal pressure in cirrhosis
✍ Arved Winfried Schneider; Johann Friedrich Kalk; Christian Peter Klein πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 1 views

Administration of angiotensin II causes an increase in portal pressure, and plasma concentration of angiotensin II is elevated in patients with cirrhosis, suggesting that angiotensin II may be involved in the pathogenesis of portal hypertension in cirrhosis. We evaluated the effect of the orally act